Variable expression and hypermethylation of p16 gene in patients with T-ALL and cell lines

Turkish Journal of Haematology

Volumn 19, Issue 3, 2002, Pages 391-397

  Özkul, Yusuf ^a   Jurickova, Ingrid ^b   Findley, Harry W ^b  

^a ERCIYES UNIVERSITY   (Turkey)

^b EMORY UNIVERSITY   (United States)

Author keywords

Acute lymphoblastic leukemia (ALL); Expression; Methylation; p16; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; PROTEIN P15; PROTEIN P16;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER PATIENT; CHILD; CHILDHOOD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DNA METHYLATION; GENE DELETION; GENE INACTIVATION; GENE LOCATION; GENE LOCUS; GENE LOSS; GENE REARRANGEMENT; HEMATOLOGIC MALIGNANCY; HEMIZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; METHYLATION; PROTEIN EXPRESSION; RESTRICTION MAPPING; SOUTHERN BLOTTING; T CELL LEUKEMIA; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 0036964171     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hirama T, Koeffler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995;86:841-54.
2. Delmer A, Tang R, Senamaud-Beaufort C, Paterlini P, Brechot C, Zittoun R. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTSI) gene structure and expression in acute lymphoblastic leukemias. Leukemia 1995;9:1240-5.
3. Wang QM, Lones JB, Studzinski GP. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 1996;56:264-7.
4. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen JW, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler HF. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTSI/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 1995;86:755-60.
5. Ogawa S, Hirano N, Sato N, Takahashi T, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 1994;84:2431.
6. Serrano M, Hannon GJ, Beach DA. New regulatory motif in cellcycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704.
7. Stone S, Jiang P, Dayananth P, Tavtinian SV, Katcher H, Parry D, Peters G, Kamb A. Complex structure and regulation of the p16 (MTSI) lacus. Cancer Res 1995;55:2988.
8. Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW, Anderson MW. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: The location of a putative tumor suppressor gene. Cancer Res 1997;57:1-6.
9. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D. A novel p16INK4A transcript. Cancer Res 1995;55:2995.
10. Siebert R, Willers CP, Schamm A, Fossa A, Dresen IMG, Uppenkamp M, Nowrousian MR, Seeber S, Opalka B. Homozygous loss of the MTSI/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines. Br J Haematol 1995;91:3550.
11. Guran S, Tunca Y, Imirzalioglu N. Hereditary TP53 codon 292 and somatic P16(INK4A) codon 94 mutations in a Li-Fraumeni syndrome family. Cancer Genet Cytogenet 1999;113:145-51.
12. Cowan JM, Halaban R, Francke U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Nat Cancer Inst 1988;80:1159-64.
13. Herman JG, Merlo a, Mao LI, et al. Inactivation of the CDK2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in ALL common human cancer. Cancer Res 1995;55:4525-30.
14. Drexler HG. Review of alterations of the cyclin-dependent kinase inhibited INK4 family gene p16, p15, p18 and p19 in human leukemia and lymphoma cells. Leukemia 1998;12:845-59.
15. Herman JG, Latif F, Weng W, Lerman M, Zbar B, Liu B, Samid D, Duan DS, Gnara JR, Linehan WM, Baylin SB. Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994;91:9700-4.
16. Issa JP, Ottaviona YL, Celona P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the estrogen receptor CpG island links aging and neoplasia in human colon. Nat Genet 1994;7:536-40.
17. Gonzalez-Zulueta M, Bender CM, Yang AS, Ngung T, Beart RW, Tornout JMV, Jones PA. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Research 1995;55:4531-5.
18. Costello JF, Berger M, Huang HS, Cavenee WK. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatid condensation. Cancer Research 1996;56:2405-10.
19. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5-prime CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995;1:686-92.
20. Guo SX, Taki T, Ohnishi H, et al. Hypermethylation of p16 and p15 gene and RD protein expression in acute leukemia. Leuk Res 2000;24:39-46.
21. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPJ, Davidson NE, Sidrnsky D, Baylin SB. Inactivation of the CDKN2/p16/MTSI gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-30.
22. Zhou M, Gu L, James CD, He J, Yeager AM, Smith SD, Findley HW. Homozygous deletions of the CDKN2(MTSI/p16 INK4) gene in cell lines established from children with acute lymphoblastic leukemia. Leukemia 1995;9:1159.
23. Yu AL, Batova A, Diccianni MB, Pullent J, Link MP, Yu J. Preferential inactivation of p15INK4B but not p16INK4A by hypermethylation in T-cell acute lymphoblastic leukemia. ASH Meeting 1996;1408.
24. Chim CS, Liang R, Tam CY, Kwong YL. Methylation of p15 and p16 genes in acute promyelocytic leukemia: Potential diagnostic and prognostic significance. J Clin Oncol 2001;19:2033-40.
25. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G. The alternative product from the human CDKN2A locus, p14 (ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998;17:5001-14.
26. Otterson GA, Kratzke A, Conox A, Kim YW, Kaye FJ. Absence of p16 INK4 is restricted to the subset of lung cancer lines that retains wild type RB. Oncogene 1994;9:3375.